World's Best Scientists 2026 revealed!
Katie L. Flanagan

Katie L. Flanagan

D-Index & Metrics

Immunology

D-Index
48
Citations
15201
World Ranking
4385
National Ranking
183

Katie L. Flanagan publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Katie L. Flanagan sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 175 publications — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Katie L. Flanagan D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Katie L. Flanagan sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 48 D-Index — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Katie L. Flanagan is affiliated with RMIT University in Australia and has an extensive research portfolio primarily within the fields of Medicine and Immunology and Microbiology. Their work includes a focus on Immunology, Infectious Diseases, Epidemiology, Health, and General Health Professions.

The research topics covered by Katie L. Flanagan encompass:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Immune responses and vaccinations
  • Vaccine Coverage and Hesitancy
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Vaccines and immunoinformatics approaches

Katie L. Flanagan has published frequently in several scientific venues, with multiple articles appearing in:

  • Frontiers in Immunology
  • SSRN Electronic Journal
  • Proceedings of the National Academy of Sciences
  • Nature Communications
  • The Journal of Immunology

Some recent publications include:

  • "Suboptimal SARS-CoV-2−specific CD8 + T cell response associated with the prominent HLA-A*02:01 phenotype" (2020, Proceedings of the National Academy of Sciences)
  • "Systems serology detects functionally distinct coronavirus antibody features in children and elderly" (2021, Nature Communications)
  • "CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity" (2021, Immunity)
  • "RSV Prevention in All Infants: Which Is the Most Preferable Strategy?" (2022, Frontiers in Immunology)
  • "The non-specific and sex-differential effects of vaccines" (2020, Nature Reviews Immunology)

Frequent collaborators include:

  • Katherine Kedzierska
  • Magdalena Plebanski
  • Carolien E. van de Sandt
  • Thi H. O. Nguyen
  • Jamie Rossjohn

Best Publications

  • Sex differences in immune responses

    Sabra L. Klein;Katie L. Flanagan

  • Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.

    Samuel J McConkey;William H H Reece;Vasee S Moorthy;Daniel Webster

  • Sex and Gender Differences in the Outcomes of Vaccination over the Life Course.

    Katie L. Flanagan;Ashley L. Fink;Magdalena Plebanski;Sabra L. Klein

  • Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis.

    Samuel Nyamweya;Andrea Hegedus;Andrea Hegedus;Assan B Jaye;Sarah L Rowland-Jones

  • The microgenderome revealed: sex differences in bidirectional interactions between the microbiota, hormones, immunity and disease susceptibility

    Ravichandra Vemuri;Kristyn E. Sylvia;Sabra L. Klein;Samuel C. Forster

  • Potent Induction of Focused Th1-Type Cellular and Humoral Immune Responses by RTS,S/SBAS2, a Recombinant Plasmodium falciparum Malaria Vaccine

    A. Lalvani;P. Moris;G. Voss;A. A. Pathan

  • Heterologous Immunological Effects of Early BCG Vaccination in Low-Birth-Weight Infants in Guinea-Bissau: A Randomized-controlled Trial

    Kristoffer Jarlov Jensen;Nanna Larsen;Sofie Biering-Sørensen;Andreas Andersen

  • RSV Prevention in All Infants: Which Is the Most Preferable Strategy?

    Unknown

  • Suboptimal SARS-CoV-2-specific CD8 + T cell response associated with the prominent HLA-A*02:01 phenotype.

    Jennifer R. Habel;Thi H.O. Nguyen;Carolien E. van de Sandt;Carolien E. van de Sandt;Jennifer A. Juno

  • Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines.

    Susanna Esposito;Paola Stefanelli;Norman Fry;Giorgio Fedele

  • Systems serology detects functionally distinct coronavirus antibody features in children and elderly.

    Kevin J. Selva;Carolien E. van de Sandt;Carolien E. van de Sandt;Melissa M. Lemke;Christina Y. Lee

  • Identification of a human neonatal immune-metabolic network associated with bacterial infection.

    Claire Lindsay Smith;Paul Dickinson;Thorsten Forster;Marie H Craigon

  • Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum.

    Magdalena Plebanski;Katie L Flanagan;Edwin A.M Lee;William H.H Reece

  • Age-Dependent Maturation of Toll-Like Receptor-Mediated Cytokine Responses in Gambian Infants

    Sarah Burl;Sarah Burl;John Townend;Jainaba Njie-Jobe;Momodou Cox

  • Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2 + Tregs within the tumor microenvironment

    Chindu Govindaraj;Karen Scalzo-Inguanti;Mutsa Madondo;Julene Hallo

  • CD8 + T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity.

    Thi H O Nguyen;Louise C Rowntree;Jan Petersen;Jan Petersen;Brendon Y Chua;Brendon Y Chua

  • The non-specific and sex-differential effects of vaccines.

    Peter Aaby;Christine Stabell Benn;Katie L. Flanagan;Katie L. Flanagan;Katie L. Flanagan;Sabra L. Klein

  • Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming.

    Magdalena Plebanski;Edwin A.M. Lee;Carolyn M. Hannan;Katie L. Flanagan

  • Correlation of Memory T Cell Responses against TRAP with Protection from Clinical Malaria, and CD4+ CD25high T Cells with Susceptibility in Kenyans

    Stephen M. Todryk;Stephen M. Todryk;Stephen M. Todryk;Philip Bejon;Philip Bejon;Tabitha Mwangi;Magdalena Plebanski

  • Delaying Bacillus Calmette-Guérin Vaccination from Birth to 4 1/2 Months of Age Reduces Postvaccination Th1 and IL-17 Responses but Leads to Comparable Mycobacterial Responses at 9 Months of Age

    Sarah Burl;Uche J. Adetifa;Momodou Cox;Ebrima Touray

  • Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children.

    S Jayasooriya;T I de Silva;J Njie-jobe;C Sanyang

  • Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19.

    Shidan Tosif;Shidan Tosif;Melanie R Neeland;Philip Sutton;Paul V Licciardi

Frequent Co-Authors

Magdalena Plebanski
Magdalena Plebanski RMIT University
Adrian V. S. Hill
Adrian V. S. Hill University of Oxford
Hilton Whittle
Hilton Whittle London School of Hygiene & Tropical Medicine
Sarah Rowland-Jones
Sarah Rowland-Jones University of Sheffield
Nigel Curtis
Nigel Curtis Royal Children's Hospital
Jamie Rossjohn
Jamie Rossjohn Monash University
Katherine Kedzierska
Katherine Kedzierska University of Melbourne
Stephen J. Kent
Stephen J. Kent University of Melbourne
Christine Stabell Benn
Christine Stabell Benn University of Southern Denmark
Peter Aaby
Peter Aaby University of Southern Denmark

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, pursuing advanced nursing degrees can offer valuable career progression. Many professionals consider transitioning from roles such as Family Nurse Practitioner to more specialized positions like Acute Care Nurse Practitioner. Resources on how to transition from fnp to acnp provide practical guidance for making this shift smoothly.

Accelerated educational pathways are gaining popularity, enabling students to complete their nursing qualifications faster. The nurse practitioner accelerated program options offer comprehensive online curricula designed to fast-track your entry or advancement in the nursing field.

For individuals without prior nursing credentials, entering the field is now more accessible than ever. There are flexible online rn programs for non nurses in florida that provide foundational training and licensure preparation, accommodating various schedules and lifestyles.

Additionally, finding convenient and affordable programs plays a crucial role in career development. If you seek quicker enrollment, exploring the accelerated nursing programs near me can identify nearby options tailored to your needs and geographic location.

Best Scientists Citing Katie L. Flanagan

Trending Scientists

Recently Published Articles